[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100562969":3},{"organization":4,"armGroups":7,"interventions":30,"overallOfficials":21,"centralContacts":42,"locations":21,"responsibleParty":48,"collaborators":52,"id":59,"slug":60,"hasResults":61,"nctId":62,"briefTitle":63,"officialTitle":64,"acronym":65,"eligibilityCriteria":66,"healthyVolunteers":61,"sex":67,"minAge":21,"maxAge":21,"enrollmentInfo":68,"targetDuration":21,"studyType":71,"phases":72,"briefSummary":74,"conditions":75,"keywords":78,"overallStatus":83,"whyStopped":21,"lastUpdateSubmitDate":84,"lastUpdatePostDateStruct":85,"startDateStruct":88,"completionDateStruct":90,"leadSponsor":92,"locationsCount":21},{"fullName":5,"class":6},"The Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College","OTHER",[8,14,18,22,25,28],{"label":9,"type":10,"description":11,"interventionNames":12},"Patients with DFSP in the first experimental group","EXPERIMENTAL","The ICG was injected intravenously 24 hours before surgery at a dose of 0.25 mg\u002Fkg in the first experimental group.",[13],"Drug: ICG administration",{"label":15,"type":10,"description":16,"interventionNames":17},"Patients with DFSP in the second experimental group","The ICG was injected intravenously 24 hours before surgery at a dose of 25 mg\u002Fpatient in the second experimental group.",[13],{"label":19,"type":20,"description":21,"interventionNames":21},"Patients with DFSP in the control group","NO_INTERVENTION",null,{"label":23,"type":10,"description":11,"interventionNames":24},"Patients with sSCC in the first experimental group",[13],{"label":26,"type":10,"description":16,"interventionNames":27},"Patients with sSCC in the second experimental group",[13],{"label":29,"type":20,"description":21,"interventionNames":21},"Patients with sSCC in the control group",[31,35,37,40],{"type":32,"name":33,"description":11,"armGroupLabels":34,"otherNames":21},"DRUG","ICG administration",[9],{"type":32,"name":33,"description":16,"armGroupLabels":36,"otherNames":21},[15],{"type":32,"name":33,"description":38,"armGroupLabels":39,"otherNames":21},"The ICG was injected intravenously 24 hours before surgery at a dose of 0.25 mg\u002Fkg in the first experimental group",[23],{"type":32,"name":33,"description":16,"armGroupLabels":41,"otherNames":21},[26],[43],{"name":44,"role":45,"phone":46,"phoneExt":21,"email":47},"Dr. Han","CONTACT","+86-15001222456","hanyudi_301@foxmail.com",{"type":49,"investigatorFullName":50,"investigatorTitle":51,"investigatorAffiliation":5,"oldNameTitle":21,"oldOrganization":21},"PRINCIPAL_INVESTIGATOR","Lei Cui","Principal Investigator",[53,55,57],{"name":54,"class":6},"Peking University Third Hospital",{"name":56,"class":6},"Chinese PLA General Hospital",{"name":58,"class":6},"Peking University International Hospital","100562969","phase-1-nifr-image-guided-surgery-for-malignant-soft-tissue-tumor-with-low-dose-swig-technique-100562969",false,"NCT06610071","NIFR Image-guided Surgery for Malignant Soft Tissue Tumor With Low-dose SWIG Technique","Near-infrared Fluorescence Image-guided Surgery for Malignant Soft Tissue Tumor With Low-dose Second Window Indocyanine Green Technique: a Multicenter Randomized Controlled Trial","NIFR;SWIG","Inclusion Criteria:\n\n* Patients with DFSPs or sSCC in heads, extremities or trunk\n\nExclusion Criteria:\n\n* seafood\u002Fiodine allergy\n* hyperthyroidism\n* pregnancy\n* myasthenia gravis\n* acute severe hypertension","ALL",{"count":69,"type":70},592,"ESTIMATED","INTERVENTIONAL",[73],"PHASE1","This research study will evaluate how near-infrared fluorescence (NIRF) imaging with low-dose second window indocyanine green (ICG) can assist in the radical resection and pathologic diagnosis of malignant soft tissue sarcoma, such as dermatofibrosarcoma protuberans (DFSP) and skin squamous cell carcinoma (sSCC) during surgery.",[76,77],"Dermatofibrosarcoma Protuberans (DFSP)","Skin Squamous Cell Carcinoma",[79,80,81,82],"near-infrared fluorescence imaging","second window indocyanine green","dermatofibrosarcoma protuberans","skin squamous cell carcinoma","NOT_YET_RECRUITING","2024-09-19",{"date":86,"type":87},"2024-09-24","ACTUAL",{"date":89,"type":70},"2024-10-30",{"date":91,"type":70},"2030-12-30",{"name":5,"class":6}]